Prescient Therapeutics Ltd has released a press release.
Despatch of Entitlement Offer Documents
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- Prospectus
- Capital Raising Presentation - March 2019
- Prescient Completes Equity Raising to Raise $9.1 Million
- December 2018 Appendix 4C - Quarterly
- Interim Durability Analysis of PTX-200 Breast Cancer Study
Later from Prescient Therapeutics
- March 2019 Appendix 4C - Quarterly
- Entitlement Offer Results and Shortfall Notification
- Canadian Patent Granted for PTX-200
- Change to Exercise Price of Options
- PTX Initiates Phase 1b Clinical Trial for PTX-100
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics